velpatasvir

ORF1a polyprotein;ORF1ab polyprotein ; Severe acute respiratory syndrome coronavirus 2







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34823857 Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2. 2022 Feb 1
2 33168456 Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach. 2020 Dec 1